Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acids comprising a modified rodent activin a receptor type 1 (Acvr1) gene

Nucleic acids comprising a modified rodent activin a receptor type 1 (Acvr1) gene

US Patent 12089576 · Granted Sep 17, 2024

Estimated economic value: $68,266,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for modifying a genome2025
Anti-TMPRSS6 antibodies and uses thereof2025
Anti-CD63 antibodies, conjugates, and uses thereof2025
Compositions and methods for internalizing enzymes2025
Anti-ACVR1 antibodies and uses thereof2024
Anti-ACVR1 antibodies and uses thereof2024
Anti-ACVR1 antibodies and uses thereof2024
Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital l2023
Human antibodies to GREM12023
Human antibodies to GREM12023
Multispecific antigen-binding molecules binding to a target and an internalizing2023
Genetically modified rodent with an inducible ACVR1 mutation in exon 7 that caus2022